70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast CancerFátima Cardoso, Martine Piccart, Laura J. van’t Veer et al.|New England Journal of Medicine|2016Cited by 2k
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal CancerRamón Salazar, Rob A.�E.�M. Tollenaar, Hans Morreau et al.|Journal of Clinical Oncology|2010Cited by 540
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trialLajos Pusztai, Laura J. Esserman, Christina Yau et al.|Cancer Cell|2021Cited by 330
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancerMarieke E. Straver, Sjoerd Rodenhuis, Annuska M. Glas et al.|Breast Cancer Research and Treatment|2009Cited by 256
<i>CHEK2</i>*1100delC Heterozygosity in Women With Breast Cancer Associated With Early Death, Breast Cancer–Specific Death, and Increased Risk of a Second Breast CancerMaren Weischer, Annegien Broeks, Børge G. Nordestgaard et al.|Journal of Clinical Oncology|2012Cited by 180